• Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD

  • Aug 26 2024
  • Duración: 15 m
  • Podcast

Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.  

     Episode outline:  

    • Moving beyond lipid lowering to address residual inflammatory risk
    • Novel anti-inflammatory targets for ASCVD

    To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

    • CME-certified text module with animated pathophysiology video and faculty voice audio clips
    • ClinicalThought commentaries
    • Podcast episode 1, discussing residual risk associated with systemic inflammation and the role of cardiologists and nephrologists in mitigating risk in ASCVD and CKD
    • Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles